Accredited official statistics

MRSA, MSSA, Gram-negative bacteraemia and CDI: quarterly report

Trends in meticillin resistant (MRSA) and meticillin susceptible (MSSA) Staphylococcus aureus, Gram-negative bacteraemia and Clostridioides difficile infection.

From:
UK Health Security Agency
Published
14 October 2021
Last updated
23 January 2025 鈥� See all updates

Applies to England

Documents

Quarterly epidemiological commentary: mandatory Gram-negative bacteraemia, MRSA, MSSA and C. difficile infections (data up to July to September 2024)

Ref: GOV-17941

HTML

Quarterly infographic: MRSA, MSSA and Gram-negative bacteraemia and CDI, data up to July to September 2024

Ref: GOV-17941

HTML

Ref: GOV-17941

MS Excel Spreadsheet, 131 KB

Quarterly epidemiological commentary: mandatory Gram-negative bacteraemia, MRSA, MSSA and C. difficile infections (data up to April to June 2024)

Ref: GOV-17381

HTML

Quarterly infographic: MRSA, MSSA and Gram-negative bacteraemia and CDI, data up to April to June 2024

Ref: GOV-17381

HTML

Ref: GOV-17381

ODS, 81.7 KB

This file is in an OpenDocument format

Quarterly epidemiological commentary: Mandatory Gram-negative bacteraemia, MRSA, MSSA and C. difficile infections (data up to January to March 2024)

Ref: GOV-16938

HTML

Quarterly infographic: MRSA, MSSA and Gram-negative bacteraemia and CDI, January to March 2024

Ref: GOV-16938

HTML

Ref: GOV-16938

ODS, 78.8 KB

This file is in an OpenDocument format

Quarterly epidemiological commentary: Mandatory Gram-negative bacteraemia, MRSA, MSSA and C. difficile infections (data up to October to December 2023)

Ref: GOV-16489

HTML

Quarterly infographic: MRSA, MSSA and Gram-negative bacteraemia and CDI, October to December 2023

Ref: GOV-16489

HTML

Ref: GOV-16489

ODS, 76.6 KB

This file is in an OpenDocument format

Quarterly epidemiological commentary: Mandatory Gram-negative bacteraemia, MRSA, MSSA and C. difficile infections (data up to July to September 2023)

Ref: GOV-16082

HTML

Quarterly infographic: MRSA, MSSA and Gram-negative bacteraemia and CDI, July to September 2023

Ref: GOV-16082

HTML

Ref: GOV-16082

ODS, 75.9 KB

This file is in an OpenDocument format

Quarterly epidemiological commentary: Mandatory Gram-negative bacteraemia, MRSA, MSSA and C. difficile infections (data up to April to June 2023)

Ref: GOV-15559

HTML

Quarterly infographic: MRSA, MSSA and Gram-negative bacteraemia and CDI, April to June 2023

Ref: GOV-15559

HTML

Ref: GOV-15559

ODS, 72.4 KB

This file is in an OpenDocument format

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Quarterly epidemiological commentary: Mandatory Gram-negative bacteraemia, MRSA, MSSA and C. difficile infections (data up to January to March 2023)

Ref: GOV-15011

HTML

Quarterly infographic: MRSA, MSSA and Gram-negative bacteraemia and CDI, January to March 2023

Ref: GOV-15011

HTML

Ref: GOV-15011

ODS, 72.4 KB

This file is in an OpenDocument format

Quarterly epidemiological commentary: Mandatory Gram-negative bacteraemia, MRSA, MSSA and C. difficile infections (data up to October to December 2022)

Ref: GOV-14531

HTML

Quarterly infographic: MRSA, MSSA and Gram-negative bacteraemia and CDI, October to December 2022

Ref: GOV-14531

HTML

Ref: GOV-14531

ODS, 66.8 KB

This file is in an OpenDocument format

Quarterly epidemiological commentary: mandatory Gram-negative bacteraemia, MRSA, MSSA and C. difficile infections (data up to July to September 2022)

Ref: GOV-14099

HTML

Quarterly infographic: MRSA, MSSA and Gram-negative bacteraemia and CDI, July to September 2022

Ref: GOV-14099

HTML

Ref: GOV-14099

ODS, 65.4 KB

This file is in an OpenDocument format

Quarterly epidemiological commentary: mandatory Gram-negative bacteraemia, MRSA, MSSA and C. difficile infections (data up to April to June 2022)

Ref: GOV-13395

HTML

Ref: GOV-13395

ODS, 66.2 KB

This file is in an OpenDocument format

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Quarterly infographic: MRSA, MSSA and Gram-negative bacteraemia and CDI, April to June 2022

Ref: GOV-13395

HTML

Quarterly epidemiological commentary: mandatory MRSA, MSSA and Gram-negative bacteraemia, and C. difficile infection data (up to January to March 2022)

HTML

Ref: UKHSA publications gateway number GOV-12644

ODS, 59.1 KB

This file is in an OpenDocument format

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Quarterly infographic: MRSA, MSSA and Gram-negative bacteraemia and CDI, January to March 2022 (text version)

HTML

Ref: UKHSA publications gateway number GOV-12644

PDF, 458 KB, 2 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Quarterly epidemiological commentary: mandatory Gram-negative bacteraemia, MRSA, MSSA and C. difficile infections data (up to October to December 2021)

HTML

Ref: UKHSA publication gateway number GOV-11768

PDF, 1.13 MB, 29 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Ref: UKHSA publication gateway number GOV-11768

ODS, 57.7 KB

This file is in an OpenDocument format

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Quarterly infographic: MRSA, MSSA and Gram-negative bacteraemia and CDI, October to December 2021 (text version)

Ref: UKHSA publication gateway number GOV-11768

HTML

Ref: UKHSA publication gateway number GOV-11768

PDF, 396 KB, 2 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Ref: UKHSA - Gateway GOV - 10754

PDF, 463 KB, 30 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

ODS, 55.3 KB

This file is in an OpenDocument format

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

https://khub.net/documents/135939561/174099494/Quarterly+infographic+-+MRSA%2C+MSSA+and+Gram-negative+bacteraemia+and+CDI+-+July+to+September+2021.pdf/7172e2b8-7239-dad0-6515-53e2ae41d674

Ref: UKHSA- Gateway GOV-10037

PDF, 1.55 MB, 24 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

ODS, 49.1 KB

This file is in an OpenDocument format

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

https://khub.net/documents/135939561/174099494/QEC+infographic+April+to+June+2021.pdf/9130098a-ef71-14f1-b855-8a7cce04d3eb

Details

Further information

These official statistics were independently reviewed by the Office for Statistics Regulation in May 2022. They comply with the standards of trustworthiness, quality and value in the and should be labelled 鈥榓ccredited official statistics鈥�. Accredited official statistics are called National Statistics in the Statistics and Registration Service Act 2007. Further explanation of accredited official statistics can be found on the .

From September 2017

The commentaries contain national aggregated data and an overview of the trends in the mandatory reports of healthcare associated infection (HCAI) 鈥� meticillin resistant Staphylococcus aureus (MRSA), meticillin susceptible Staphylococcus aureus (MSSA) and Gram-negative bacteraemia and Clostridioides difficile (C. difficile) infection 鈥� over recent quarters.

For previous quarterly commentaries and associated data please see:

Older quarterly commentaries and associated data are also available from the .

Enquiries or feedback

For any enquiries or feedback on these reports, or to request copies of any web-based reports in PDF format, please contact [email protected]

Updates to this page

Published 14 October 2021
Last updated 23 January 2025 show all updates

  1. Added data, report and infographic for July to September 2024.

  2. Added back missing sections to the report which were accidentally omitted during the publishing process.

  3. Added data, report and infographic for April to June 2024.

  4. Small decimal point differences in the overall and community-onset rates have been made in the January to March 2024 quarterly report, as quarter 4 of the financial year 2023 to 2024 national population estimate did not account for the leap year. These corrections do not affect the direction of trends.

  5. Added data, report and infographic for January to March 2024.

  6. Added data, report and infographic for October to December 2023.

  7. Added data, report and infographic for July to September 2023.

  8. Added data, report and infographic for April to June 2023.

  9. Added data, report and infographic for January to March 2023. Also corrected heading in October to December 2022 report.

  10. Added data, report and infographic for October to December 2022.

  11. Added data, report and infographic for July to September 2022.

  12. Added report, accompanying data and infographic for April to June 2022.

  13. Added report for January to March 2022 and accompanying data.

  14. Added October to December 2021 report, spreadsheet and infographic.

  15. Added July to September 2021 quarterly epidemiological commentary and accompanying data.

  16. Added April to June 2021 infographic.

  17. First published.

Sign up for emails or print this page

Related content